Fumiyasu Endo

St. Luke's International Hospital

Papers

10

Total Citations

100

H-Index

5

About

Fumiyasu Endo is a leading urologic surgeon and researcher whose work centers on refining robot-assisted radical prostatectomy (RARP) for prostate cancer. His major contributions span three key areas: preventing postoperative complications, optimizing lymph node dissection, and defining surgical learning curves. Endo is best known for developing a novel, simplified technique to prevent inguinal hernia after RARP—a common complication—using no artificial materials, with long-term results showing durable efficacy (39 and 7 citations). He has also advanced the use of indocyanine green-guided extended pelvic lymph node dissection (ePLND) to improve staging accuracy in intermediate- to high-risk patients (21 citations), while critically evaluating whether ePLND offers a true therapeutic benefit (4 citations). His work using cumulative sum analysis to derive institutional and surgeon-specific learning curves for RARP (8 citations) provides a data-driven framework for surgical training. Endo’s research addresses practical, high-impact challenges in robotic urologic oncology, directly improving patient outcomes and surgical safety. His publications, with over 100 total citations, reflect a focused, clinically relevant body of work that informs both current practice and future innovation in prostate cancer surgery.

Research Focus

Key Achievements

5
H-Index
10
Papers
100
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Incidence, Risk Factors and a Novel Prevention Technique for Inguinal Hernia after Robot-Assisted Radical Prostatectomy
39 citations · 2016
📈 Most Prolific Year: 2020 (3 Papers)
🤝 Key Collaborators: 44
🏛 Institutions: St. Luke's International Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago